Adalimumab Adalimumab (Humira) is a biological, fully human, recombinant immunoglobulin G (IgG) anti-TNF monoclonal antibody (mAb) with high affinity, used for the treatment of numerous autoimmune and inflammatory disease conditions, including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn's disease, and ulcerative colitis
Call +1 303 800 4326 or Send us a message for a personalized consultation
A small clinical study in healthy volunteers shows that pretreatment with quercetin increases plasma levels and prolongs the half-life of a single dose of cyclosporine (Neoral, Sandimmune), a substrate of CYP3A4
5 Plus, given the critical role glutathione plays at the cellular and mitochondrial levels, the overall health and longevity benefits are vast and wide